Healthcare
Autologous CAR-T cell therapies: 3 ways pharma companies are addressing their manufacturing challenges
There are many challenges related to the manufacturing and supply chain needs to produce autologous CAR-T cell therapies. How do they impact delivery times and cost to the patient? How are some ...









